Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18015
Abstract: Secukinumab is administered at the labelled dose of 300 mg at weeks 0, 1, 2, 3, 4 (loading dose) and every 4 weeks thereafter. read more here.
Keywords: efficacy secukinumab; initial weekly; without initial; secukinumab ... See more keywords
The efficacy of secukinumab with continued use in the treatment of psoriasis
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18653
Abstract: Affecting at least 100 million people worldwide, psoriasis is a disease causing red, scaly patches of skin that may cover a large area of the body and may also affect the nails, scalp, palms and… read more here.
Keywords: efficacy secukinumab; continued use; use treatment; treatment psoriasis ... See more keywords
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
Sign Up to like & getrecommendations! Published in 2023 at "Clinical, Cosmetic and Investigational Dermatology"
DOI: 10.2147/ccid.s378135
Abstract: Purpose Psoriasis, a common systemic inflammatory disorder, presents with gender-related differences in the quality of life (QoL) and treatment outcomes. This post hoc analysis from the Phase 3b SUPREME study explored gender-related differences in patient… read more here.
Keywords: efficacy secukinumab; supreme study; dermatology; gender ... See more keywords